CPHI KOREA 2026

CPHI Korea 2026: Asia's Premier Pharmaceutical Hub in Seoul

Scheduled for August 25-27, 2026, CPHI Korea will return to the vibrant heart of Asia's pharmaceutical industry, Seoul, South Korea. As the cornerstone event for the Asian pharma supply chain, CPHI Korea 2026 is poised to be the definitive gathering for professionals across the entire spectrum of drug development and manufacturing. Building on its established reputation, this edition promises to be even larger and more impactful, reflecting the dynamic growth and innovation within the Asian and global pharmaceutical sectors.

Core Content & Focus Areas:

CPHI Korea 2026 will be a comprehensive showcase and knowledge-sharing platform, centered around several key pillars:

1. Exhibition Hall: The Heart of Innovation: The vast exhibition floor will be the nucleus of activity, featuring thousands of exhibitors showcasing:
APIs & Intermediates: Leading suppliers of active pharmaceutical ingredients and key intermediates.
Excipients & Formulation: Cutting-edge ingredients and technologies for drug formulation development and manufacturing.
Biologics & Biosimilars: A dedicated zone highlighting advancements in biologics development, manufacturing technologies, and the rapidly evolving biosimilar market.
Packaging & Labelling: Innovative solutions for primary and secondary packaging, ensuring safety, compliance, and patient convenience.
Contract Development & Manufacturing (CDMO/CMO): Extensive representation of CDMOs and CMOs offering end-to-end services from R&D to commercial-scale production.
Analytical & Lab Technology: State-of-the-art equipment, instruments, and services for quality control, R&D, and process monitoring.
Logistics & Supply Chain: Solutions for cold chain management, warehousing, and distribution tailored to pharmaceuticals.

2. Conference Programme: Shaping the Future: A robust lineup of conferences, seminars, and workshops will delve into critical industry trends and challenges:
Regulatory Updates: Deep dives into evolving regulations in Korea, Asia-Pacific, and globally (e.g., ICH guidelines).
Market Access & Pricing: Strategies for navigating complex healthcare systems and securing reimbursement.
Sustainability & Green Pharma: Focus on environmentally sustainable manufacturing practices and reducing the industry's carbon footprint.
Digital Transformation: Leveraging AI, data analytics, and automation in R&D, manufacturing, and supply chain management.
Emerging Technologies: Exploring novel modalities like cell & gene therapy, mRNA, and advanced therapies.
Korea Pharma Market Insights: Dedicated sessions on the unique opportunities and dynamics of the South Korean pharmaceutical market.

3. Networking & Business Development: Beyond the exhibits and sessions, CPHI Korea facilitates crucial connections:
Pre-arranged Meetings: Advanced scheduling tools enabling targeted B2B meetings between buyers and suppliers.
Networking Zones: Dedicated areas for informal discussions and relationship building.
Industry Associations & Pavilion Zones: Clustering of national pavilions and association delegations, fostering regional collaboration.

Why Attend CPHI Korea 2026?

Access Asia's Growth Engine: Connect directly with the dynamic Asian pharma market, leveraging South Korea's strategic position and advanced manufacturing capabilities.
Discover Innovation Source: Source the latest technologies, services, and partners for every stage of the pharma value chain.
Gain Strategic Insights: Learn from industry leaders and regulators about future trends, regulations, and market strategies.
Expand Your Network: Build relationships with thousands of potential partners, clients, and peers from across the globe.
Position for the Future: Understand the forces shaping the future of pharmaceuticals and secure your competitive advantage.

CPHI Korea 2026 in Seoul is not just an event; it's an essential strategic platform for anyone invested in the global pharmaceutical supply chain. Mark your calendars for August 25-27, 2026, and plan to be at the forefront of Asia's pharma evolution.